in this issue
World News and Views :: Top of the News
Bayer to acquire birth control firm Conceptus for $1.1 billion
7:01 AM MDT | April 29, 2013 | Natasha Alperowicz
Bayer HealthCare has signed a merger agreement with Conceptus (Mountain View; CA), the developer of the Essure procedure—a leading nonsurgical, permanent birth-control method, Bayer announced today. The move aims to broaden Bayer’s portfolio in the field of contraception. Bayer, following the acquisition, will be able to offer a complete range of short-term, long-term, and permanent contraceptive choices for women, the company says. Bayer will launch a public tender offer to acquire all shares in Conceptus within the next...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee